Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 1

Interventions

Cyclophosphamide 21fludarabine phosphate 13Cyclosporine 11Antilymphocyte Serum 11Peripheral Blood Stem Cell Transplantation 10Methotrexate 10Busulfan 10Cytarabine 9Filgrastim 8Radiotherapy 7Dexamethasone 7Whole-Body Irradiation 6Mycophenolic Acid 6Methylprednisolone 6Melphalan 6Exercise 6fludarabine 5Vincristine 5Daunorubicin 5Cord Blood Stem Cell Transplantation 5pegaspargase 4Rituximab 4Palliative Care 4Mercaptopurine 4Etoposide 4Early Intervention, Educational 4Blood Specimen Collection 4Asparaginase 4Alemtuzumab 4Thioguanine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia × calaspargase pegol × Clear all
NCT01225874 2016-02-23

Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL

Children's Oncology Group

Phase NA Completed
3,762 enrolled
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡